Browse the evidence

Age-related diseases (ARDs) and geriatric syndromes are not distinct entities but represent accelerated aging trajectories driven by the same molecular mechanisms as normal aging.

Focus on interventions that target shared aging mechanisms (like chronic inflammation and oxidative stress) rather than just treating individual diseases as they appear. This approach, known as geroscience, suggests that slowing aging may prevent or delay multiple age-related conditions simultaneously.

Elevated levels of the transcriptional coactivator PGC-1α protect skeletal muscle from atrophy by suppressing the transcriptional activity and binding of the FoxO3 transcription factor to atrophy-related genes (atrogin-1 and MuRF-1).

To maintain muscle mass, especially during periods of stress, illness, or reduced activity, prioritize metabolic health and regular movement. This helps keep PGC-1α levels high, which naturally blocks the molecular signals (FoxO3) that trigger muscle breakdown. While this doesn't replace resistance training for growth, it is a critical defense against muscle loss.

Acute or intermittent administration of the flavonoid fisetin acts as a senolytic to clear senescent cells, thereby reducing age-related pathology and extending both healthspan and lifespan in aged mice.

Fisetin is a potent senolytic that extends healthspan and lifespan in mice when administered intermittently at high doses (e.g., 100 mg/kg body weight for 5 days). While human trials are beginning, current evidence supports an intermittent 'hit-and-run' dosing strategy rather than daily supplementation to maximize efficacy and minimize potential side effects. Consult a physician before starting high-dose supplementation.

High intrahepatic triglyceride (IHTG) content, rather than visceral adipose tissue (VAT) volume, is the primary independent marker and driver of metabolic complications (insulin resistance and dyslipidemia) in obesity.

If you are obese, your liver fat content is a more critical indicator of your metabolic health than your waist size. While reducing visceral fat is good, strategies that specifically target liver fat accumulation (such as reducing fructose intake or alcohol, and improving insulin sensitivity) may yield better metabolic outcomes than focusing solely on waist circumference reduction.

Dietary supplements containing ephedra alkaloids pose a serious health risk, causing adverse cardiovascular and central nervous system events including hypertension, stroke, seizures, and death, even in previously healthy individuals at low doses.

Avoid dietary supplements containing ephedra alkaloids (ma huang). These products have been linked to heart attacks, strokes, seizures, and death, even in healthy people taking low doses. The potential for severe, permanent injury or fatality outweighs any unproven weight loss or energy benefits.

Reducing dietary carbohydrate intake to low levels (24 g/day) in obese individuals significantly decreases fecal butyrate concentrations and reduces the abundance of butyrate-producing bacteria (specifically Roseburia spp. and Eubacterium rectale).

If you follow a very low-carbohydrate diet (like Keto), you may see a significant drop in butyrate, a beneficial compound for colon health. This happens because you are feeding fewer of the bacteria that produce it. To mitigate this, consider including specific fermentable fibers or resistant starches even on a low-carb diet to support these bacteria.

Adipokines, specifically leptin and adiponectin, play opposing roles in cancer development, with leptin promoting tumor growth and adiponectin offering protection.

Obesity alters hormone secretion from fat cells: it increases leptin (which fuels cancer) and decreases adiponectin (which protects against cancer). Weight loss helps restore this balance.

The SenMayo gene set (125 genes) accurately identifies senescent cells across tissues and species, and its expression levels significantly decrease following genetic or pharmacological clearance of senescent cells, serving as a reliable biomarker for senolytic efficacy.

SenMayo is a validated 125-gene signature that can detect senescent cells in various tissues (bone, brain, fat) and track their reduction after senolytic treatments (like Dasatinib + Quercetin). It is currently a research tool for monitoring senolytic efficacy, not a standard clinical test yet.

Obesity promotes aggressive breast cancer behavior (growth, invasion, metastasis) through a mechanism involving hypoxia-induced inflammation, increased aromatase expression, and stimulation of cancer stem cells.

Weight loss interventions aim to break the cycle of obesity-driven inflammation and estrogen production, thereby reducing the fuel for tumor growth and metastasis.

Obesity is associated with an increased risk of triple-negative breast cancer (TNBC) in premenopausal women, whereas this association is null or inverse in postmenopausal women.

For premenopausal women, obesity specifically increases the risk of the more aggressive triple-negative breast cancer subtype. Weight management is particularly crucial in this demographic.

Metabolic syndrome prevalence in US adults increased significantly from 1988 to 2012, reaching over 34% by 2012, driven by rising obesity, age, and low socioeconomic status.

Your risk of metabolic syndrome is not fixed. The data shows it has been rising for everyone, but it is strongly linked to obesity, age, and income. Focus on maintaining a healthy weight and accessing healthcare early, especially if you are in a lower socioeconomic bracket, to mitigate these risks.

Non-Hispanic black men have a lower likelihood of metabolic syndrome compared to non-Hispanic white men, while non-Hispanic black women have a higher likelihood compared to non-Hispanic white women.

If you are a Black man, your risk is statistically lower than White men, but still significant. If you are a Black woman, your risk is higher than White women. Regardless of race, managing weight and socioeconomic factors (like access to care and healthy food) are critical levers for reducing your personal risk.

Low education level and advanced age are independently associated with an increased likelihood of metabolic syndrome, regardless of obesity status.

If you have less education or are older, your risk is higher. This isn't just about willpower; it's about access. Focus on finding affordable, healthy food options and safe places to be active. Community-level changes, like better access to healthcare and fresh food, are crucial for mitigating these risks.

Antibiotic exposure during early development (prenatal, perinatal, or early childhood) disrupts microbiome succession, leading to long-term health consequences including increased susceptibility to infection, immunological disorders (asthma, type 1 diabetes), and metabolic shifts toward obesity or malnutrition.

Avoid antibiotics for viral infections or minor issues, especially in children. If antibiotics are necessary, discuss probiotic or dietary strategies to support microbiome recovery with your doctor, as early-life antibiotic use is linked to long-term health risks like asthma and obesity.

Broad-spectrum antibiotic use in developed countries contributes to reduced microbiome diversity compared to hunter-gatherer societies, which is associated with increased susceptibility to infection and metabolic disorders.

Be mindful of antibiotic use. While they are essential for serious bacterial infections, unnecessary use contributes to a less diverse gut microbiome, which is linked to higher risks of metabolic and immune disorders. Prioritize dietary diversity to support microbiome health.

Higher birth weight is directly associated with higher attained Body Mass Index (BMI) in later life, indicating that fetal growth patterns program long-term adiposity risk.

Your body's fat storage set point may be influenced by your growth in the womb. While you cannot change your birth weight, understanding this link highlights why early childhood nutrition and avoiding excessive fetal growth (in diabetic pregnancies) are critical for preventing adult obesity.

Lower birth weight is inversely associated with central (abdominal) obesity and metabolic syndrome risk after adjusting for attained adult BMI, creating a 'small baby, high BMI' phenotype with elevated cardiovascular risk.

If you were born small but became overweight as an adult, your risk for heart disease and diabetes is significantly higher than someone who was born larger and became overweight. Focus on preventing childhood obesity and managing abdominal fat, as this specific combination is a major driver of metabolic syndrome.

High glucose levels independently regulate gene expression through the transcription factor ChREBP, which is activated by glucose metabolites (xylulose 5-phosphate) to promote lipogenesis and glycolysis, even in the absence of insulin.

High carbohydrate intake directly signals your liver and fat cells to produce fat and break down glucose for energy, independent of insulin levels, via a specific protein (ChREBP).

Fasting and low glucose levels trigger transcriptional changes that promote gluconeogenesis and fatty acid oxidation via the activation of transcription factors like CREB, PGC1, and PPARs, counteracting insulin's effects.

When you fast, your body switches to producing glucose and burning fat by turning on specific genes (via CREB and PGC1). This is a natural survival mechanism.

There is a massive gap between objective sleep apnea severity and clinical diagnosis, with 84-93% of individuals with moderate-to-severe SDB remaining undiagnosed across all racial groups.

Do not rely on a doctor's diagnosis to rule out sleep apnea. If you have risk factors (race, obesity, snoring), seek objective testing, as the vast majority of moderate-to-severe cases go undiagnosed.

Testosterone replacement therapy significantly decreases serum leptin levels in older hypogonadal men, suggesting a hormonal modulation of adiposity regulation.

Testosterone therapy in hypogonadal men has been shown to lower leptin levels, a hormone involved in regulating body fat and hunger. This suggests testosterone may help modulate body composition, although this study did not show significant changes in body fat percentage or BMI.

Visceral adipose tissue (VAT) volume is independently associated with systemic inflammation and oxidative stress, even after adjusting for overall obesity measures like BMI and waist circumference.

If you are concerned about inflammation, focusing solely on total body weight (BMI) is insufficient. Visceral fat, located deep in the abdomen, is a stronger predictor of inflammatory markers like CRP and IL-6 than subcutaneous fat. While you cannot directly 'target' visceral fat loss with spot-reduction exercises, general weight loss and exercise tend to reduce visceral fat effectively. Monitoring waist circumference may be a more practical proxy for visceral fat risk than BMI alone.

Globalization-driven policies (agricultural trade liberalization, foreign direct investment in food processing, and global marketing) structurally increase the availability, lower the cost, and enhance the desirability of energy-dense, processed foods, thereby driving a nutrition transition characterized by increased consumption of fats and sweeteners and rising rates of obesity and diet-related chronic diseases.

To address obesity and chronic disease, policy makers must look beyond individual education and regulate the structural drivers of the food environment, including agricultural trade policies, foreign investment in food processing, and global marketing practices that make unhealthy foods cheaper and more available.

Insulin resistance drives nonalcoholic fatty liver disease (NAFLD) progression through increased free fatty acid flux from adipose tissue to the liver, leading to hepatic triglyceride accumulation and impaired glucose metabolism.

Fatty liver is fundamentally a metabolic disorder driven by insulin resistance, not just a result of eating too much fat or sugar. Even lean people can develop it. Treating the underlying insulin resistance (e.g., through exercise, weight management, or medication) is key to managing the liver disease, rather than just focusing on liver-specific diets.